Metallic radionuclides possess a variety of half-lives, emission types, energies, and
branching ratios, making it possible to apply them as diagnostic and/or therapeutic agents …

Therapeutic radiopharmaceuticals have been researched extensively in the last decade as
a result of the growing research interest in personalized medicine to improve diagnostic …

The present paper comprehensively reviews group 3–7 metal NHC complexes reported
since 2014, with emphasis on their current applications and fundamental reactivity. Thanks …

To pursue the design of in vivo stable chelating systems for radiometals, a concise and
straightforward method toolbox was developed combining NMR, isothermal titration …

The first part of the review summarizes more than three decades of research on cyclen
complexes, with a particular focus on complexes that exhibit hydrolytic (or transesterification) …

The 64Cu-labeled chelator was analyzed in vivo by positron emission tomography (PET)
imaging to evaluate its biodistribution in a murine model at different acquisition times. For …

Emerging pollutants (EPs) have become a global concern, attracting tremendous attention
because of serious threats to human and animal health. EP diversity emanates from their …

Studies concerning the development of radiopharmaceuticals based on the Tc (I) carbonyl
core are considered from the coordination-chemical viewpoint. The coordination behavior of …

Extensive angiogenesis is a characteristic feature in the synovial tissue of rheumatoid
arthritis (RA) from a very early stage of the disease onward and constitutes a crucial event …

Targeted radionuclide therapy (TRNT) is an ever-expanding field of nuclear medicine that
provides a personalised approach to cancer treatment while limiting toxicity to normal …